Clinical development of novel therapeutics for castration-resistant prostate cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 299, doi. 10.3322/caac.21141
- By:
- Publication type:
- Article
Works matching IS 00079235 AND DT 2012 AND VI 62 AND IP 5
Results: 8
1
2
Adjuvant chemotherapy benefits older and younger non-small cell lung cancer patients alike.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 279, doi. 10.3322/caac.21151
- By:
- Publication type:
- Article
3
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Hormone receptor status affects locoregional control in HER2-positive breast cancer treated with trastuzumab.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 281, doi. 10.3322/caac.21152
- By:
- Publication type:
- Article
5
Electronic patient-reported outcome systems in oncology clinical practice.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 336, doi. 10.3322/caac.21150
- By:
- Publication type:
- Article
6
Erratum.
- Published in:
- 2012
- Publication type:
- Erratum
7
Immunotherapy of cancer in 2012.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. 309, doi. 10.3322/caac.20132
- By:
- Publication type:
- Article
8
Cancer statistics for Hispanics/Latinos, 2012.
- Published in:
- CA: A Cancer Journal for Clinicians, 2012, v. 62, n. 5, p. n/a, doi. 10.3322/caac.21153
- By:
- Publication type:
- Article